EP2726074
COMBINATION THERAPY COMPRISING A CDK4/6 INHIBITOR AND A PI3K INHIBITOR FOR USE IN THE TREATMENT OF CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
2.7.2012EP published:
4.4.2018EP application number:
12735408.2
EPO information:
European Patent Register
Max expiry date:
1.7.2032
Title:
COMBINATION THERAPY COMPRISING A CDK4/6 INHIBITOR AND A PI3K INHIBITOR FOR USE IN THE TREATMENT OF CANCER
Timeline
Today
2.7.2012EP application
4.4.2018EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
KIM, SunkyuAddress:
Cambridge, Massachusetts, US
Name:
DOSHI, ShivangAddress:
Cambridge, Massachusetts, US
Name:
HAAS, KristyAddress:
Cambridge, Massachusetts, US
Name:
KOVATS, StevenAddress:
Cambridge, Massachusetts, US
Name:
HUANG, Alan XizhongAddress:
Cambridge, Massachusetts, US
Name:
CHEN, YanAddress:
Cambridge, Massachusetts, US
Priority
Number:
201161503642 PDate:
1.7.2011Country:
US
Classification
Categories:
A61K 31/4439, A61K 31/519, A61K 31/5377, A61K 45/06, A61P 35/00